0

Journal Articles

in Adverse Drug Effects
 21-40 of 109 Articles
Editorial |  February 11, 2013
Opioid Prescriptions for Chronic Nonmalignant Pain:  Driving on a Dangerous Road
Mitchell H. Katz, MD
JAMA Intern Med. 2013;173(3):178. doi:10.1001/jamainternmed.2013.1838.
Editor's Correspondence |  February 11, 2013
Medication Reconciliation Practices and Potential Clinical Impact of Unintentional Discrepancies
Bruno Michel, PharmD, PhD; Bapiste Quelennec, PharmD; Emmanuel Andres, MD, PhD
JAMA Intern Med. 2013;173(3):246-247. doi:10.1001/jamainternmed.2013.1235.
Editor's Correspondence |  February 11, 2013
New Statins Also Produce Fatigue: Spontaneous Reporting as a Complementary System to Increase Safety Knowledge
Mónica Tarapués, MD; Gloria Cereza, MD; Albert Figueras, MD
JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.1614.
Editor's Correspondence |  February 11, 2013
New Statins Also Produce Fatigue: Spontaneous Reporting as a Complementary System to Increase Safety Knowledge—Reply
Beatrice A. Golomb, MD, PhD; Sabrina Koperski, BS
JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.2113.
Editor's Correspondence |  January 28, 2013
Correcting the Record on Dietary Supplement Regulation
Douglas MacKay, ND
JAMA Intern Med. 2013;173(2):166-167. doi:10.1001/2013.jamainternmed.1028.
Editor's Correspondence |  January 28, 2013
Correcting the Record on Dietary Supplement Regulation—Reply
Donald M. Marcus, MD; Arthur P. Grollman, MD
JAMA Intern Med. 2013;173(2):166-167. doi:10.1001/jamainternmed.2013.1747.
Correction |  January 14, 2013
Errors in Text and Table 1 in: Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System
JAMA Intern Med. 2013;173(1):14. doi:10.1001/jamainternmed.2013.3143.
Editor's Correspondence |  January 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/2013.jamainternmed.753.
Editor's Correspondence |  January 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?—Reply
Raphael P. H. Meier, MD; Rene Rizzoli, MD; Robin E. Peter, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/jamainternmed.2013.1238.
Original Investigation |  December 10, 2012
Enoxaparin Outcomes in Patients With Moderate Renal Impairment
Douglas D. DeCarolis, PharmD; Joey G. Thorson, PharmD; Megan A. Clairmont, PharmD; et al.
Arch Intern Med. 2012;172(22):1713-1718. doi:10.1001/2013.jamainternmed.369.
INCLUDES: CME
Invited Commentary |  December 10, 2012
Moderate Renal Impairment and Risk of Bleeding With Anticoagulation:  Comment on “Enoxaparin Outcomes in Patients With Moderate Renal Impairment”
Tracy Minichiello, MD
Arch Intern Med. 2012;172(22):1718-1720. doi:10.1001/2013.jamainternmed.456.
Original Investigation |  December 10, 2012
Supratherapeutic Dosing of Acetaminophen Among Hospitalized Patients
Li Zhou, MD, PhD; Saverio M. Maviglia, MD, MS; Lisa M. Mahoney, RPh; et al.
Arch Intern Med. 2012;172(22):1721-1728. doi:10.1001/2013.jamainternmed.438.
Invited Commentary |  December 10, 2012
Using Health Information Technology to Improve Health Care: Emphasizing Speed to Value:  Comment on “Supratherapeutic Dosing of Acetaminophen Among Hospitalized Patients”
Walter H. Ettinger, MD, MBA
Arch Intern Med. 2012;172(22):1728-1729. doi:10.1001/2013.jamainternmed.607.
Original Investigation |  December 10, 2012
The Risk of Hip Fracture After Initiating Antihypertensive Drugs in the Elderly
Debra A. Butt, MD, MSc, CCFP, FCFP; Muhammad Mamdani, PharmD, MPH; Peter C. Austin, PhD; et al.
Arch Intern Med. 2012;172(22):1739-1744. doi:10.1001/2013.jamainternmed.469.
INCLUDES: , Supplemental Content
Original Investigation |  November 12, 2012
Zonisamide for Weight Reduction in Obese Adults:  A 1-Year Randomized Controlled Trial
Kishore M. Gadde, MD; Mariko F. Kopping, MS, RD; H. Ryan Wagner, PhD; et al.
Arch Intern Med. 2012;172(20):1557-1564. doi:10.1001/2013.jamainternmed.99.
INCLUDES: , Supplemental Content
Original Investigation |  November 12, 2012
Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System
Sengwee Toh, ScD; Marsha E. Reichman, PhD; Monika Houstoun, PharmD; et al.
Arch Intern Med. 2012;172(20):1582-1589. doi:10.1001/2013.jamainternmed.34.
INCLUDES: CME , Supplemental Content
Invited Commentary |  November 12, 2012
No Place for Novel Oral Anticoagulants in Current Treatment of Acute Coronary Syndromes:  Comment on “Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome”
Adrian V. Hernandez, MD, PhD
Arch Intern Med. 2012;172(20):1546-1547. doi:10.1001/2013.jamainternmed.293.
Review Article |  November 12, 2012
Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome:  Systematic Review and Meta-analysis of Randomized Controlled Trials
András Komócsi, MD, PhD; András Vorobcsuk, MD, PhD; Dániel Kehl, MS; et al.
Arch Intern Med. 2012;172(20):1537-1545. doi:10.1001/archinternmed.2012.4026.
INCLUDES: , Supplemental Content
Original Investigation |  October 22, 2012
Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding
Daniel M. Witt, PharmD, FCCP, BCPS; Thomas Delate, PhD; David A. Garcia, MD; et al.
Arch Intern Med. 2012;172(19):1484-1491. doi:10.1001/archinternmed.2012.4261.
INCLUDES: , Supplemental Content
Invited Commentary |  October 22, 2012
Resuming Anticoagulation in the First Week Following Gastrointestinal Tract Hemorrhage:  Comment on “Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding”
Daniel J. Brotman, MD; Amir K. Jaffer, MD
Arch Intern Med. 2012;172(19):1492-1493. doi:10.1001/archinternmed.2012.4309.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Original Contribution  |  May 01, 2013
Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants:  A Randomized Trial
Sina Gallo, RD, MSc; Kathryn Comeau, RD, MSc; Catherine Vanstone, RN, MSc; et al.
JAMA
Original Contribution  |  April 24, 2013
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Jakob Christensen, PhD; Therese Koops Grønborg, MSc; Merete Juul Sørensen, PhD; et al.
JAMA
Editorial  |  April 24, 2013
Risks of In Utero Exposure to Valproate
Kimford J. Meador, MD; David W. Loring, PhD
JAMA
Health Agencies Update  |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems